PIDTC: Hematopoietic Stem Cell Transplantation Using Carrier Donors for CD40L Deficiency Results in Excellent Outcomes
Sep 7, 2022 ·
1m 54s
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood Advances on June 28, 2022, titled "HSCT using...
show more
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood Advances on June 28, 2022, titled "HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh."
Read the paper here: https://ashpublications.org/bloodadvances/article/6/12/3751/485000/HSCT-using-carrier-donors-for-CD40L-deficiency
Learn more about PIDTC: https://www1.rarediseasesnetwork.org/cms/pidtc
show less
Read the paper here: https://ashpublications.org/bloodadvances/article/6/12/3751/485000/HSCT-using-carrier-donors-for-CD40L-deficiency
Learn more about PIDTC: https://www1.rarediseasesnetwork.org/cms/pidtc
Information
| Author | RDCRN |
| Organization | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
